Lotvin Alan's Form 4 filing
CVS Health CorpCVS · filed Aug 5, 2022
- Accession no.
- 0001127602-22-020596
- Filed
- Aug 5, 2022
- Trade date
- Aug 3-4, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $14.2M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lotvin AlanCIK 0001472795 | Officer (EVP&President-PharmacyServices) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2022 | Common Stock | MOption exerciseAcquired | +70,398 | $58.34 | +$4,107,019.32 | 179,581.37 | Direct | |
| Aug 3, 2022 | Common Stock | SSaleDisposed | −70,398 | $98.00 | −$6,899,004 | 109,183.37 | Direct | |
| Aug 3, 2022 | Common Stock | MOption exerciseAcquired | +50,501 | $54.19 | +$2,736,649.19 | 159,684.37 | Direct | |
| Aug 3, 2022 | Common Stock | SSaleDisposed | −50,501 | $98.00 | −$4,949,098 | 109,183.37 | Direct | |
| Aug 4, 2022 | Common Stock | MOption exerciseAcquired | +22,541 | $62.21 | +$1,402,275.61 | 131,724.37 | Direct | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −22,541 | $104.00 | −$2,344,264 | 109,183.37 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2022 | Common Stock | MOption exerciseDisposed | −70,398 | $0.00 | $0 | 70,399 | Direct | |
| Aug 3, 2022 | Common Stock | MOption exerciseDisposed | −50,501 | $0.00 | $0 | 20,201 | Direct | |
| Aug 4, 2022 | Common Stock | MOption exerciseDisposed | −22,541 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.